The prognostic utility of dihomo-gamma-linolenic acid (DGLA) in patients with acute coronary heart disease
- 1 December 2017
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 249, 12-17
Abstract
No abstract availableKeywords
Funding Information
- Western Norway Regional Health Authority
This publication has 20 references indexed in Scilit:
- Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory ProcessesEuropean Journal of Pharmacology, 2016
- Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort StudiesCirculation, 2014
- Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary RiskAnnals of Internal Medicine, 2014
- (n-3) Fatty Acid Content of Red Blood Cells Does Not Predict Risk of Future Cardiovascular Events following an Acute Coronary SyndromeThe Journal of Nutrition, 2009
- Omega-6 Fatty Acids and Risk for Cardiovascular DiseaseCirculation, 2009
- Omega-6 and trans fatty acids in blood cell membranes: A risk factor for acute coronary syndromes?American Heart Journal, 2008
- Long-chain conversion of [13C]linoleic acid and α-linolenic acid in response to marked changes in their dietary intake in menJournal of Lipid Research, 2005
- Importance of Dietary γ-Linolenic Acid in Human Health and NutritionThe Journal of Nutrition, 1998
- Dietary Supplementation with γ-Linolenic Acid Alters Fatty Acid Content and Eicosanoid Production in Healthy Humans ,The Journal of Nutrition, 1997
- Antithrombotic potential of dihomo-gamma-linolenic acid in man.BMJ, 1977